M Dong, J Zhang, X Ma, J Tan, L Chen, S Liu… - Biomedicine & …, 2020 - Elsevier
At the end of 2019, the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Currently, it is …
H Ibrahim, A Perl, D Smith, T Lewis, Z Kon… - Clinical …, 2020 - Elsevier
Abstract Glucose 6-phosphate dehydrogenase (G6PD) deficiency facilitates human coronavirus infection due to glutathione depletion. G6PD deficiency may especially …
Y Tian, X Qiu, C Wang, J Zhao, X Jiang… - … journal of cancer, 2021 - Wiley Online Library
Evidence is mounting to indicate that cancer patients may have more likelihood of having coronavirus disease 2019 (COVID‐19) but lack consistency. A robust estimate is urgently …
L Yang, P Chai, J Yu, X Fan - Cancer Biology & Medicine, 2021 - ncbi.nlm.nih.gov
Objective: Patients with underlying diseases are more vulnerable to coronavirus disease 2019 (COVID-19). The purpose of this study was to investigate cancer incidence in patients …
F Saponaro, G Rutigliano, S Sestito… - Frontiers in Molecular …, 2020 - frontiersin.org
Angiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and …
S Atlante, A Mongelli, V Barbi, F Martelli, A Farsetti… - Clinical …, 2020 - Springer
Epigenetics is a relatively new field of science that studies the genetic and non-genetic aspects related to heritable phenotypic changes, frequently caused by environmental and …
OA Badary, MS Hamza, R Tikamdas - Drug design, development …, 2021 - Taylor & Francis
COVID-19 has caused a major global health crisis, as excessive inflammation, oxidation, and exaggerated immune response in some sufferers can lead to a condition known as …
Abstract Angiotensin-converting enzyme 2 (ACE2) is an important player of the renin- angiotensin-aldosterone system (RAAS) in regulating the conversion of angiotensin II into …
M Jacobs, HP Van Eeckhoutte… - European …, 2020 - Eur Respiratory Soc
Angiotensin-converting enzyme 2 (ACE2) has been identified as the cell entry receptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[1, 2]. Importantly …